kaposi
sarcoma
associ
herpesviru
kshv
establish
persist
infect
human
host
infect
human
b
cell
circul
infect
host
like
constitut
major
latent
reservoir
kshv
reactiv
spread
addit
strong
associ
kshv
primari
effus
lymphoma
pel
plasma
cell
variant
multicentr
castleman
diseas
strongli
suggest
caus
role
viru
pathogenesi
b
cell
diseas
thu
human
b
cell
like
compris
import
compart
persist
kshv
infect
studi
latent
lytic
life
cycl
b
cell
focu
mani
studi
past
replic
transcript
activ
rta
kshv
immedi
earli
protein
activ
broad
spectrum
lytic
viral
gene
therebi
induc
lytic
reactiv
rta
either
directli
bind
rtarespons
element
use
cellular
dna
bind
factor
like
adaptor
dna
review
dna
bind
factor
cpromot
bind
factor
suppressor
hairless
also
design
csl
highli
conserv
ubiquit
express
protein
major
effector
notch
receptor
signal
follow
use
term
protein
serv
adaptor
transactiv
also
recruit
corepressor
complex
therebi
silenc
gene
express
two
gener
experiment
strategi
focuss
cellular
interact
partner
viral
genom
use
studi
function
implic
interact
initi
infect
viru
product
profici
defici
murin
fibroblast
studi
isogen
system
studi
suggest
lytic
reactiv
block
establish
latenc
impair
cell
lack
altern
comput
predict
potenti
bind
site
viral
genom
follow
biochem
mutat
analysi
respect
viral
promot
promot
report
assay
context
viral
genom
recombin
viru
technolog
addit
activ
viral
target
activ
notch
defin
set
depend
promot
summari
studi
convincingli
show
contribut
activ
pan
well
latenc
transcript
cluster
summar
referenc
tabl
importantli
gene
control
multipl
stage
viral
latent
lytic
life
cycl
relev
contribut
target
gene
control
vari
among
individu
gene
studi
thu
question
remain
extent
activ
contribut
process
viral
reactiv
viru
product
human
b
cell
vitro
broad
spectrum
cell
line
deriv
divers
tissu
infect
kshv
human
b
cell
b
cell
line
appear
refractori
infect
recent
product
infect
primari
b
cell
could
accomplish
lead
long
term
prolifer
infect
cell
infect
lymphoblastoid
b
cell
line
bjab
cellassoci
recombin
viru
cultiv
infect
bjab
cell
select
medium
stabl
latent
infect
cultur
gener
howev
viral
reactiv
attenu
virion
product
almost
block
human
b
cell
render
unsuit
address
role
lytic
reactiv
goal
studi
analyz
contribut
viral
lytic
reactiv
kshv
infect
human
b
cell
end
infect
isogen
defici
profici
human
b
cell
line
recombin
kshv
compar
viral
reactiv
viru
product
result
indic
viral
reactiv
initi
profici
defici
b
cell
viral
gene
express
sever
attenu
viru
product
detect
level
absenc
addit
viral
gene
alreadi
known
control
could
identifi
two
direct
depend
rta
target
gene
order
analyz
contribut
viral
reactiv
kshv
infect
b
cell
use
neg
human
somat
b
cell
line
cell
line
gener
previous
gene
target
cellular
gene
ebv
neg
burkitt
lymphoma
b
cell
line
infect
profici
parent
wt
defici
ko
cell
use
cell
cultur
supernat
recombin
viru
produc
vero
cell
recombin
viru
deriv
kshv
strain
obtain
cell
encod
red
fluoresc
protein
rfp
control
independ
fragment
kshv
earli
lytic
pan
promot
constitut
express
green
fluoresc
protein
gfp
carri
puromycin
resist
cassett
select
marker
wt
ko
cell
infect
multipl
infect
moi
factor
gfp
express
monitor
flow
cytometri
time
cours
week
gfp
posit
cell
popul
could
detect
week
post
infect
intens
gfp
signal
record
flow
cytometri
initi
weak
increas
time
profici
defici
b
cell
line
fig
result
suggest
stabl
homogen
kshv
infect
b
cell
cultur
gener
within
week
post
infect
irrespect
statu
high
gfp
express
remain
stabl
long
cultur
maintain
media
contain
puromycin
fig
establish
infect
wt
ko
cell
line
wt
ko
cultiv
absenc
puromycin
gfp
neg
popul
develop
profici
defici
b
cell
still
gfp
posit
cultiv
puromycin
free
media
week
fig
henc
viral
mainten
requir
select
b
cell
line
viral
genom
copi
number
establish
wt
ko
cell
line
determin
compar
data
obtain
two
independ
kshv
infect
pel
cell
line
expect
intracellular
genom
detect
cell
wt
ko
cell
carri
approxim
viral
copi
per
cell
fig
cell
line
profici
defici
express
kshv
latent
marker
gene
similar
level
fig
consist
express
latent
infect
cell
differ
tissu
origin
requir
maintain
episom
viral
genom
cell
divis
latent
express
seen
kshv
infect
b
cell
rel
transcript
level
viral
gene
lower
cell
readili
detect
distinct
express
level
might
partial
reflect
lower
viral
genom
copi
number
cell
line
compar
next
examin
viru
reactiv
cell
line
upon
treatment
sodium
butyr
nab
surrog
earli
lytic
marker
gene
rfp
induc
express
similar
frequenc
two
independ
wt
ko
cell
line
fig
combin
tpa
nab
enhanc
rfp
express
neglig
differ
wt
ko
cell
fig
initi
lytic
reactiv
thu
appear
depend
process
b
cell
next
analyz
profici
defici
cell
line
exhibit
similar
rate
viral
replic
upon
lytic
reactiv
tpanab
treatment
rate
dead
cell
determin
treat
untreat
cell
popul
trypan
blue
exclus
assay
tpanab
treatment
caus
similar
rate
dead
cell
popul
fig
viabl
subpopul
defin
forward
sideward
scatter
signal
fig
rfpgfp
cell
separ
cell
cell
sort
equal
number
sort
cell
compar
number
intracellular
viral
genom
viral
copi
number
increas
profici
defici
cell
increas
profici
cell
two
fold
stronger
fig
sinc
lytic
viral
replic
impair
defici
b
cell
investig
whether
viru
product
also
attenu
b
cell
treat
tpa
nab
day
supernat
harvest
concentr
use
infect
cell
cell
cultur
either
presenc
absenc
puromycin
h
subsequ
analyz
gfp
express
fluoresc
microscopi
fig
addit
cellular
viabil
monitor
flow
cytometri
use
forward
sideward
scatter
visual
viabl
dead
cell
popul
fig
gfp
posit
cell
readili
detect
infect
wt
cell
supernat
ko
cell
produc
extrem
low
number
virion
confer
gfp
express
second
marker
success
infect
test
whether
viral
supernat
confer
puromycin
resist
fig
e
inde
cell
infect
viral
supernat
harvest
wt
cell
could
expand
presenc
puromycin
cell
infect
supernat
ko
cell
lost
typic
shape
adher
phenotyp
subsequ
die
fig
result
suggest
supernat
deriv
defici
cell
contain
low
amount
infecti
viru
confirm
assumpt
extracellular
viral
genom
copi
number
wt
ko
deriv
supernat
quantifi
compar
virion
dna
produc
viru
product
induc
upon
chemic
reactiv
wt
cell
approxim
higher
cell
contrast
virion
product
defici
cell
bare
detect
fig
summari
data
show
cell
produc
infecti
viru
genom
replic
attenu
defici
cell
later
process
requir
morphogenesi
infecti
viru
block
order
examin
differ
viral
reactiv
reflect
alter
viral
gene
express
pattern
analyz
lytic
viral
gene
express
profici
defici
cell
h
post
induct
nab
viral
gene
express
profil
analyz
use
previous
develop
realtim
rtpcr
array
kshv
repres
viral
gene
result
genom
wide
analysi
viral
reactiv
profici
defici
cell
shown
heat
map
fig
gene
arrang
group
latent
earli
late
lytic
gene
review
induct
lytic
viral
gene
could
observ
profici
defici
cell
sever
attenu
delay
defici
cell
differ
profici
defici
cell
pronounc
h
post
induct
select
viral
gene
retest
realtim
rtpcr
choos
primer
distinct
primer
use
array
analysi
fig
result
confirm
lytic
gene
induc
profici
defici
cell
degre
induct
differ
differ
best
seen
late
time
point
viral
replic
alreadi
initi
latent
express
chang
dramat
chemic
induct
latent
induc
profici
cell
alreadi
seen
array
analysi
depend
gene
induct
confin
specif
gene
class
thu
appear
requir
multipl
stage
reactiv
process
chemic
induct
kshv
infect
cell
typic
lead
reactiv
subset
cellular
popul
thu
sort
latent
rfpgfp
lytic
popul
test
induct
immedi
earli
gene
earli
lytic
gene
expect
differ
gene
express
profici
defici
cell
pronounc
select
subset
analyz
fig
order
confirm
result
reintroduc
flagtag
version
protein
ko
cell
line
express
construct
use
carri
bidirect
doxycyclin
respons
promot
induct
gene
interest
monitor
flow
cytometri
surrog
marker
truncat
version
ngfreceptor
cell
surfac
stabl
cell
line
carri
express
construct
show
doxycyclin
depend
ngfreceptor
express
cell
carri
control
vector
express
ngfreceptor
fig
b
next
induct
seri
lytic
viral
gene
test
ko
cell
induc
doxycyclin
two
independ
induc
cell
line
test
compar
two
control
cell
line
induct
lytic
viral
gene
restor
even
exceed
level
reach
wt
fig
observ
indic
endogen
cellular
protein
level
rate
limit
viral
reactiv
cell
major
transactiv
addit
known
enhanc
rta
function
multifunct
protein
enhanc
splice
translat
effici
support
export
intronless
viral
mrna
stabil
transcript
one
dna
polymeras
process
factor
necessari
origin
depend
viral
replic
sinc
induct
diminish
defici
cell
defect
rta
express
could
alreadi
caus
sever
phenotyp
defici
cell
henc
want
ask
express
might
rescu
defici
defici
cell
thu
express
cell
induc
lytic
cycl
nab
could
strongli
enhanc
express
nab
treat
profici
cell
induct
absenc
weak
fig
result
suggest
lack
induct
rate
limit
factor
viral
reactiv
defici
b
cell
summari
analysi
viral
gene
express
profil
shown
induct
lytic
gene
class
block
attenu
defici
b
cell
viral
gene
previous
defin
gene
need
recruit
either
rta
notch
list
tabl
order
identifi
addit
depend
viral
target
gene
promot
select
gene
carri
least
one
bind
site
predict
use
matinspector
softwar
genomatix
analyz
sinc
transcript
start
site
gene
defin
experiment
past
fragment
bp
upstream
translat
start
site
test
put
promot
transactiv
put
promot
fragment
test
transient
report
gene
assay
use
kshv
neg
cell
comparison
promot
well
known
depend
target
gene
includ
analysi
promot
respond
even
absenc
dose
depend
manner
indic
absolut
requir
recruit
rta
target
gene
activ
transcript
promot
activ
significantli
diminish
defici
cell
transactiv
promot
impair
fig
reintroduc
transactiv
promot
strongli
enhanc
confirm
rate
limit
factor
effici
activ
promot
fig
sinc
want
prove
recruit
promot
perform
chromatin
immunoprecipit
follow
realtim
pcr
viral
promot
fragment
fig
could
readili
detect
promot
cellular
target
gene
kshv
posit
neg
wt
cell
expect
seen
viral
promot
kshv
infect
wt
cell
summari
result
suggest
promot
directli
bound
protein
dna
bind
factor
highli
conserv
evolut
mammal
ubiquit
express
tissu
thu
provid
central
hub
everi
mammalian
cell
use
cell
integr
inform
transmit
extern
intern
stimuli
two
human
ebv
kshv
use
dna
adaptor
viral
nuclear
transcript
factor
control
activ
viral
cellular
target
gene
ebv
requir
protein
enter
maintain
latent
life
cycl
contrast
lytic
infect
reactiv
depend
process
kshv
infect
cell
rta
initi
viral
lytic
replic
bind
dna
directli
also
use
adaptor
regulatori
element
target
gene
rta
express
control
bind
site
within
rta
promot
therebi
rta
initi
posit
feed
back
loop
drive
lytic
reactiv
hand
lana
express
also
control
rta
via
depend
activ
lana
repress
rta
express
via
bind
rta
promot
howev
subsequ
studi
use
infect
recombin
kshv
lack
bind
site
rta
promot
demonstr
virus
enhanc
capac
infect
establish
latenc
primari
human
b
cell
short
term
experi
summari
serv
mediat
neg
posit
feed
back
loop
balanc
rta
lana
express
henc
lytic
latent
life
cycl
infect
cell
consequ
target
signal
antivir
drug
could
highli
attract
critic
stage
viru
life
cycl
relev
pathogenesi
could
effici
block
function
analysi
depend
process
hamper
ubiquit
express
human
cell
thu
first
report
describ
interact
rta
use
defici
fibroblast
deriv
knockout
mice
studi
contribut
establish
latenc
reactiv
lytic
infect
establish
latenc
impair
mous
fibroblast
reactiv
block
stage
delay
earli
gene
express
summari
data
confirm
extend
result
previou
studi
unlik
murin
fibroblast
kshv
infect
defici
b
cell
enter
lytic
cycl
low
effici
specif
block
onset
viral
replic
late
gene
express
instal
use
ident
recombin
viru
describ
recent
viral
reactiv
block
multipl
stage
viral
dna
synthesi
cbf
profici
murin
fibroblast
multipl
block
attenu
induct
lytic
cascad
defici
murin
fibroblast
previou
studi
like
explain
reactiv
human
b
cell
still
initi
goal
studi
identifi
depend
process
rate
limit
viral
reactiv
product
infecti
virus
specif
b
cell
profici
defici
kshv
infect
b
cell
line
could
establish
carri
similar
number
intracellular
viral
genom
express
similar
amount
latent
marker
gene
first
week
post
infect
gfp
express
low
detect
readili
flow
cytometri
increas
follow
week
fig
sinc
relev
process
viral
reactiv
analyz
switch
gfp
low
gfp
high
cultur
detail
point
studi
want
exclud
gfp
transfer
passiv
viral
particl
measur
flow
cytometri
earli
infect
futur
studi
reveal
whether
gfp
express
level
chang
vitro
cell
cultur
due
chang
viral
genom
copi
number
caus
epigenet
modif
viral
chromatin
sinc
kshv
infect
cell
grown
select
media
infect
process
well
establish
latent
state
cell
may
reflect
featur
infect
process
physiolog
condit
thu
present
infect
system
yet
use
studi
potenti
role
earli
phase
establish
latenc
profici
defici
b
cell
line
could
induc
rfp
report
gene
control
earli
lytic
pan
promot
profici
b
cell
could
produc
infecti
viru
viru
produc
wt
cell
induc
bright
gfp
signal
also
confer
puromycin
resist
infect
cell
fig
reactiv
lytic
cycl
initi
cell
line
howev
activ
lytic
gene
delay
defici
cell
reach
express
level
profici
cell
h
post
induct
even
day
induct
neither
extracellular
viral
genom
releas
infecti
viru
detect
transcript
depend
gene
could
rescu
even
enhanc
condit
express
thu
could
formal
prove
phenotyp
defici
cell
truli
caus
lack
ectop
express
ko
cell
induc
express
weakli
induct
rate
never
reach
level
obtain
wt
cell
thu
induct
ko
cell
essenti
singl
rate
limit
factor
reactiv
result
suggest
attenu
lytic
gene
express
level
caus
addit
effect
gene
weakli
activ
rta
absenc
viru
replic
still
detect
ko
cell
reduc
level
virion
product
entir
abolish
interestingli
could
identifi
singl
gene
activ
ko
cell
reactiv
thu
complet
depend
activ
fig
conclud
lack
pleiotrop
effect
reactiv
process
caus
direct
indirect
effect
trigger
perhap
viral
bind
protein
like
lana
antagonist
rta
function
cooper
enhanc
rta
activ
whether
cooper
rta
depend
still
need
clarifi
summar
tabl
grow
list
lytic
viral
gene
requir
activ
search
addit
viral
respons
depend
promot
put
promot
analyz
report
gene
assay
promot
studi
parallel
sinc
well
character
target
gene
rta
fig
activ
endogen
gene
requir
promot
activ
attenu
bind
site
delet
rta
dna
bind
site
retain
experi
confirm
requir
much
pronounc
endogen
gene
express
studi
result
might
suggest
chromatin
state
gene
import
impact
promot
respons
rta
could
relev
biolog
viru
sinc
viral
dna
infecti
viru
chromatin
free
unmodifi
activ
endogen
transcript
depend
activ
promot
report
construct
gene
rta
independ
exclud
use
incomplet
promot
fragment
recruit
rta
directli
carri
relev
respons
element
perhap
bind
site
locat
remot
enhanc
demonstr
recent
interact
partner
epsteinbarr
viru
nuclear
antigen
context
cellular
genom
altern
depend
effect
measur
endogen
gene
express
chromatin
depend
posttranscript
caus
attenu
lytic
cascad
defici
cell
contrast
rta
activ
promot
strongli
impair
absenc
could
rescu
ectop
express
addit
bind
promot
could
demonstr
thu
rta
target
gene
requir
direct
bind
promot
site
late
viral
gene
critic
viral
morphogenesi
viru
product
studi
develop
new
cell
cultur
model
studi
kshv
reactiv
human
b
cell
human
b
cell
line
versatil
tool
studi
kshv
mutant
cellular
background
permit
inactiv
gene
gene
target
futur
individu
kshv
loss
function
mutant
test
experi
combin
specif
variant
defici
select
cellular
protein
summari
result
obtain
novel
b
cell
system
strongli
suggest
signal
human
b
cell
pleiotrop
effect
coordin
enhanc
cours
kshv
lytic
viral
gene
induct
multipl
stage
exemplifi
two
novel
depend
late
gene
appear
global
player
requir
multipl
stage
coordin
lytic
cascad
antivir
target
signal
could
establish
would
expect
kshv
reactiv
sever
impair
cell
line
wt
ko
describ
routin
cell
line
grown
rpmi
supplement
fetal
calf
serum
fc
penicillin
uml
streptomycin
glutamin
mm
maintain
atmospher
cultur
media
contain
fc
wt
b
ko
b
cultur
media
contain
fc
puromycin
ko
b
tetctrl
b
cultur
media
contain
fc
puromycin
hygromycin
b
vero
cell
contain
kindli
provid
j
vieira
univers
washington
grown
dmem
supplement
fc
puromycin
gateway
compat
destin
vector
well
express
vector
publish
previous
vector
invitrogen
commerci
avail
pentri
construct
encod
publish
express
mammalian
cell
transfer
destin
vector
lr
reaction
invitrogen
orf
clone
contain
hygromycin
b
resist
cassett
bidirect
doxycyclin
dox
regul
promot
drive
simultan
express
truncat
ngfreceptor
addit
dox
order
gener
kshv
promot
construct
fragment
bp
upstream
translat
initi
codon
kshv
gene
amplifi
pcr
use
genom
dna
isol
cell
templat
specif
primer
contain
restrict
site
pcr
product
ligat
luciferas
report
plasmid
carri
minim
silent
promot
primer
use
clone
list
supplementari
tabl
predict
potenti
bind
site
kshv
promot
fragment
done
use
matinspector
softwar
provid
genomatix
matric
v
cgtgggaa
v
gtgggaaa
core
similar
matrix
similar
posit
promot
fragment
potenti
bind
site
viral
genom
list
supplementari
tabl
lytic
cycl
reactiv
cell
treat
sodium
butyr
nab
andor
tpa
indic
cell
per
ml
induc
viru
harvest
describ
briefli
day
post
induct
cell
pellet
supernat
filter
pores
filter
viru
concentr
wash
twice
rpmi
media
without
supplement
ultracentrifug
rpm
beckman
rotor
hour
final
viru
pellet
resuspend
volum
initi
volum
cell
cultur
medium
determin
number
infecti
viru
cell
infect
serial
dilut
viral
supernat
number
gfp
posit
cell
count
wt
ko
cell
per
ml
seed
volum
plate
follow
day
cell
infect
viru
supernat
cell
multipl
infect
moi
factor
cultur
plate
centrifug
g
min
one
day
post
infect
medium
replac
day
post
infect
select
posit
cell
start
ad
puromycin
everi
day
half
cultur
medium
replac
medium
supplement
increas
concentr
puromycin
stabl
gfp
posit
cell
line
design
wt
b
ko
b
ko
cell
transfect
vector
tripleflag
control
vector
electropor
cell
select
presenc
hygromycin
b
puromycin
stabl
cell
line
design
ko
b
tetctrl
b
digit
imag
acquir
use
openlab
acquisit
softwar
improvis
microscop
axiovert
carl
zeiss
microimag
inc
connect
chargecoupl
devic
camera
hamamatsu
infect
wt
ko
cell
cell
monitor
gfp
express
ngfreceptor
express
ko
tetctrl
cell
dox
treatment
analyz
use
primari
antibodi
atcc
isotyp
control
secondari
antibodi
dianova
fluoresc
cell
detect
analyz
use
facscalibur
system
cellquest
pro
softwar
bd
bioscienc
determin
percentag
lytic
induc
rfpgfp
cell
separ
rfpgfp
cell
cell
sort
analyz
use
facsaria
iii
cell
sorter
bd
bioscienc
flowjo
softwar
version
determin
intracellular
kshv
dna
copi
number
cell
harvest
wash
pb
resuspend
solut
mm
trishcl
ph
mm
kcl
mm
lyze
solut
b
mm
trishcl
ph
mm
tween
supplement
rnase
proteinas
k
incub
min
subsequ
min
dna
purifi
phenolchloroform
extract
extracellular
virionassoci
kshv
genom
cultur
supernat
lytic
induc
cell
isol
describ
intracellular
extracellular
viral
dna
analyz
realtim
pcr
describ
quantif
standard
curv
defin
number
pcr
fragment
kshv
genom
correspond
promot
region
gener
analyz
parallel
intracellular
kshv
copi
number
per
cell
determin
normal
primer
use
realtim
pcr
list
supplementari
tabl
wt
ko
cell
lytic
induc
mm
nab
hour
rna
extract
mrna
enrich
cdna
synthes
revers
transcript
describ
kshv
realtim
pcr
array
perform
collabor
dittmer
lineberg
comprehens
cancer
center
chapel
hill
describ
previous
dct
valu
primer
pair
kshv
gene
normal
heat
map
represent
viral
gene
express
profil
gener
use
softwar
genesi
rna
cell
extract
treat
dnase
cdna
synthes
use
high
capac
cdna
revers
transcript
kit
appli
biosystem
accord
manufactur
protocol
rel
quantif
transcript
realtim
pcr
perform
lightcycl
ii
system
data
process
lightcycl
softwar
version
roch
cdna
amplifi
use
lightcycl
sybr
green
master
mix
accord
manufactur
protocol
roch
cycl
condit
cycl
min
cycl
denatur
anneal
extens
pcr
product
examin
melt
curv
analysi
expect
pcr
fragment
size
verifi
agaros
gel
electrophoresi
account
differ
reaction
effici
standard
curv
gener
primer
pair
use
serial
dilut
pcr
product
templat
amplif
plot
cross
point
versu
known
dilut
data
normal
rel
abund
transcript
primer
use
realtim
rtpcr
list
supplementari
tabl
wt
ko
cell
transfect
indic
plasmid
dna
electropor
v
use
gene
pulser
ii
biorad
luciferas
report
gene
assay
perform
describ
previous
briefli
cell
transfect
luciferas
report
construct
indic
express
plasmid
dna
amount
adjust
ad
correspond
empti
vector
cell
harvest
h
transfect
luciferas
activ
measur
transfect
done
triplic
result
normal
activ
deriv
report
construct
includ
sampl
western
blot
analysi
perform
describ
rat
monoclon
antibodi
produc
collabor
e
kremmer
helmholtz
center
munich
publish
sigmaaldrich
millipor
antibodi
purchas
chip
analysi
perform
describ
minor
modif
use
mixtur
hybridoma
supernat
rat
monoclon
antibodi
see
supplementari
text
tabl
detail
